Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/10/731
Active ingredient: Bafetinib
Indication: Treatment of chronic myeloid leukaemia
Sponsor: Eudax Srl
Polo Tecnologico, Via Fratelli Cuzio 42, 27100 Pavia, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/06/2010 Orphan designation EMEA/OD/143/09 (2010)3902 of 10/06/2010
12/09/2012 Change of name and/or address of sponsor EMEA/OD/143/09
05/07/2013 Removal of orphan designation from Community Register